Status:
RECRUITING
Effect of Transcutaneous Electrical Nerve Stimulation on Post-stroke Patients
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Hemiplegia and/or Hemiparesis Following Stroke
Anterior Circulation Stroke of Uncertain Pathology
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The subjects will be asked to attend minimum 15 separate sessions, 6 for testing changes in reflex behaviors, 3 for testing changes in the influence of descending motor tracts on spinal motor neurons,...
Detailed Description
The subjects will be asked to attend minimum 15 separate sessions, 6 for testing changes in reflex behaviors, 3 for testing changes in the influence of descending motor tracts on spinal motor neurons,...
Eligibility Criteria
Inclusion
- Post Stroke Cohort:
- History of single unilateral stroke with subsequent lower limb hemiparesis on either side (\> 6 months since onset)
- Ability to walk as part of activities of daily living
- Age between 18 and 80
Exclusion
- Presence of concurrent severe medical illness including unhealed pressure sore, active or untreated infection, thromboembolic disease, severe contracture, osteoporosis, heterotropic classification, lower limb fracture, severe pulmonary disease or cardiovascular instability, uncontrolled seizure, uncontrolled diabetes
- History of any neurological injury other than a single stroke
- Has received a Botox injection in the lower extremity within the last 4 months
- Any cognitive deficit that would prevent informed consent or ability to perform the experiment
- History of prior injury or surgery to the hip or knee
- Presence of significant lower extremity edema - Presence of cardiac pacemaker or any other electrically implanted device - Use of braces limiting harness/Lokomat fit (Any spinal orthoses such as TLSO, HALO)
- Weight greater than 300 pounds
- Adults unable to consent, infants, children, teenagers, pregnant women and prisoners will not be included in the study
- Clinically significant depression, psychiatric disorders, or ongoing drug abuse
- Actively taking medications with agents known to increase (e.g. amphetamines) or decrease motor system excitability
- Suffered a concussion in the last 6 months.
- Unexplained headaches
- Healthy Cohort:
- Inclusion Criteria:
- No history of stroke, cerebral palsy, injury or surgery to the lower limb.
- Currently not taking any central nervous system (CNS) affecting medication.
- Ability to walk as part of activities of daily living
- Age between 18 and 80
Key Trial Info
Start Date :
June 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06541015
Start Date
June 21 2019
End Date
December 31 2025
Last Update
August 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Medical Center
Dallas, Texas, United States, 75390